6[22]Yasufs,Anand S,Avezum A,et al.Treatment for acute myocardal infarction:averview of randomioed clinical trials[J].Eur Hesrt J,1996,17(supple ):16.
7[23]Chinese Cardiac Study Collaborative Group.Oral captopril versus placebo among 13634 patients with suspected acute myocardial infarction:interim report from the Chinese Cardiac Study (CCS-1)[J].Lancet,1995,345:686-697.
8[2]The MIAMI Trial Research Group.Metoprolol in acute myocardial infarction (MIAMI).A radonised placebo controlled international trial[J].Eur Heart J,1985,6:199-211.
9[3]Beta-blocker Heart Attack Trial Reasearch Group.A randonised trial of propranolol in patients with acute myocardial infartion I mortality results[J].IAMA,1982,247:1707-1714.
10[4]ISIS-1(First Intemational Study of Infarct Survival)Collaborative Group.Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction ISIS-1[J].Lancet, 1986,(2):57-66.
6Chen J,MarciniaK TA,Radford MJ,et el.Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients[J].Am Coll Cardiol,1999;34(5):1388-94.
7Dziedzic T,Slowik A,Pera J,et al.Beta-blockers reduce the risk of early death in ischemic stroke[J].J Neurol Sci,2007;1:536.
8Boquist S,Ruotolo G,Hellenius ML,et al.Effects of a cardioselective β-blocker on postprandial triglyceride-rich lipoproteins,low density lipoprotein particle size and glucoseinsulin homeostasis in middle-aged men with modestly increased cardiovascular risk[J].Atherosclerosis,1998;137(2):391-400.
9Giugliano D,Acampora R,Marfella R,et al.Metabolic and cardiovascular effects of carvedilol and atenolol in non-Insulin-dependent diabetes mellitus and hypertension[J].Ann Inter Med,1997;126(12):955-9.
10Selvin E,Marinopoulos S,Berkenblit G,et al.Meta analysis:Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus[J].Ann Intern Med,2004;141(6):421-31.
